Why the study?
More than 5 years after the 2015 position paper and following the SARS-CoV-2 pandemic, an updated review of evidence on telemedicine and artificial intelligence in cardiovascular care was warranted.
This position paper updates the 2015 guidelines to reflect recent advancements in telemedicine and artificial intelligence for cardiovascular care, particularly in the post-COVID-19 era.
Supports integration of telemedicine and AI into cardiovascular practice; extends 2015 guidance with post-pandemic evidence.
In 2015, the Italian Society of Cardiology and its Working Group on Telemedicine and Informatics issued a position paper on Telecardiology, resuming the most eminent evidence supporting the use of information and communication technology in principal areas of cardiovascular care, ranked by level of evidence. More than 5 years later and after the global shock inflicted by the SARS-CoV-2 pandemic, an update on the topic is warranted. Recent evidence and studies on principal areas of cardiovascular disease will be therefore reported and discussed, with particular focus on telemedicine for cardiovascular care in the COVID-19 context. Novel perspectives and opportunities disclosed by artificial intelligence and its applications in cardiovascular disease will also be discussed. Finally, modalities by which machine learning have realized remote patient monitoring and long-term care in recent years, mainly filtering critical clinical data requiring selective hospital admission, will be provided.
No takes yet. Share an insight, caveat, or question.
Brunetti et al. (2023) conducted a review in Cardiovascular disease. Telemedicine and artificial intelligence was evaluated. This updated position paper discusses recent evidence on telemedicine and artificial intelligence in cardiovascular care, particularly in the context of the COVID-19 pandemic.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: